BiotechTube

Olmesartan

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Heart Disease

Conditions

Heart Disease, Arrhythmia, Atrial Fibrillation

Trial Timeline

Jan 1, 2005 → May 1, 2009

NCT ID
NCT00098137

About Olmesartan

Olmesartan is a phase 3 stage product being developed by Daiichi Sankyo for Heart Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00098137. Target conditions include Heart Disease, Arrhythmia, Atrial Fibrillation.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT01053026Pre-clinicalCompleted
NCT00098137Phase 3Completed

Competing Products

20 competing products in Heart Disease

See all competitors
ProductCompanyStageHype Score
IV diureticNuwellisPre-clinical
15
IV Loop DiureticsNuwellisPre-clinical
15
Stepped pharmacologic careNuwellisPhase 3
69
IV Loop Diuretics (LD)NuwellisPre-clinical
15
TRV120027 + Normal SalineTrevenaPhase 1
25
TRV027 Dose #1 + TRV027 Dose #2 + TRV027 Dose #3 + PlaceboTrevenaPhase 2
44
TRV120027 + PlaceboTrevenaPhase 1/2
33
Ilofotase alfa + PlaceboAM-PharmaPhase 2
44
INXN-4001PrecigenPhase 1
28
LY3461767 + PlaceboEli LillyPhase 1
33
SGLT2i, beta blocker, ARNI, MRA, MTDEli LillyApproved
85
Pactimibe, CS-505Daiichi SankyoPhase 2
52
Prasugrel 10 mg daily x 2 weeks + Clopidogrel 75 mg daily x 2 weeksDaiichi SankyoApproved
85
olmesartan medoxomil + candesartan cilexetil placebo + olmesartan medoxomil placebo + candesartan cilexetilDaiichi SankyoPhase 3
77
Carperitide + PlaceboDaiichi SankyoPhase 2
52
EdoxabanDaiichi SankyoPre-clinical
23
RegadenosonAstellas PharmaPhase 1
33
Advagraf + PrografAstellas PharmaPhase 2
52
FK506EAstellas PharmaPhase 3
77
ConivaptanAstellas PharmaApproved
85

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85